<h1>Competition approval for minority stake acquisition clears regulatory path for foreign investment in a medical device company.</h1> The Competition Commission of India approved the proposed combination for acquisition of a minority stake in Micro Life Sciences Private Limited by South Elm Investments B.V., a Netherlands investment holding company whose shareholders include private equity funds managed by Warburg Pincus. The Target manufactures and sells medical devices, in vitro diagnostics and OTC products, conducts B2C sales of specialized devices to hospitals, and maintains R&D facilities for diagnostic and surgical solutions.